Literature DB >> 27226153

Heart rate reduction in coronary artery disease and heart failure.

Roberto Ferrari1, Kim Fox2.   

Abstract

Elevated heart rate is known to induce myocardial ischaemia in patients with coronary artery disease (CAD), and heart rate reduction is a recognized strategy to prevent ischaemic episodes. In addition, clinical evidence shows that slowing the heart rate reduces the symptoms of angina by improving microcirculation and coronary flow. Elevated heart rate is an established risk factor for cardiovascular events in patients with CAD and in those with chronic heart failure (HF). Accordingly, reducing heart rate improves prognosis in patients with HF, as demonstrated in SHIFT. By contrast, data from SIGNIFY indicate that heart rate is not a modifiable risk factor in patients with CAD who do not also have HF. Heart rate is also an important determinant of cardiac arrhythmias; low heart rate can be associated with atrial fibrillation, and high heart rate after exercise can be associated with sudden cardiac death. In this Review, we critically assess these clinical findings, and propose hypotheses for the variable effect of heart rate reduction in cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27226153     DOI: 10.1038/nrcardio.2016.84

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  110 in total

1.  Heart rate and microinflammation in men: a relevant atherothrombotic link.

Authors:  O Rogowski; I Shapira; A Shirom; S Melamed; S Toker; S Berliner
Journal:  Heart       Date:  2007-01-19       Impact factor: 5.994

2.  β-blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease.

Authors:  Charlotte Andersson; David Shilane; Alan S Go; Tara I Chang; Dhruv Kazi; Matthew D Solomon; Derek B Boothroyd; Mark A Hlatky
Journal:  J Am Coll Cardiol       Date:  2014-07-22       Impact factor: 24.094

Review 3.  Revising common beliefs in the management of stable CAD.

Authors:  Roberto Ferrari
Journal:  Nat Rev Cardiol       Date:  2013-01-08       Impact factor: 32.419

Review 4.  Reduction of resting heart rate with antianginal drugs: review and meta-analysis.

Authors:  Michel Cucherat; Jeffrey S Borer
Journal:  Am J Ther       Date:  2012-07       Impact factor: 2.688

5.  Heart rate contributes to the vascular effects of chronic mental stress: effects on endothelial function and ischemic brain injury in mice.

Authors:  Florian Custodis; Karen Gertz; Mustafa Balkaya; Vincent Prinz; Ilka Mathar; Christoph Stamm; Golo Kronenberg; Andrey Kazakov; Marc Freichel; Michael Böhm; Matthias Endres; Ulrich Laufs
Journal:  Stroke       Date:  2011-04-28       Impact factor: 7.914

6.  β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.

Authors:  Sripal Bangalore; Gabriel Steg; Prakash Deedwania; Kevin Crowley; Kim A Eagle; Shinya Goto; E Magnus Ohman; Christopher P Cannon; Sidney C Smith; Uwe Zeymer; Elaine B Hoffman; Franz H Messerli; Deepak L Bhatt
Journal:  JAMA       Date:  2012-10-03       Impact factor: 56.272

7.  Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate.

Authors:  E G Nabel; A P Selwyn; P Ganz
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

8.  Ten-year mortality of patients admitted to coronary care units with and without myocardial infarction. Risk factors from medical history and diagnosis at discharge. DAVIT-Study Group. Danish Verapamil Infarction Trial.

Authors:  J Launbjerg; P Fruergaard; J K Madsen; L S Mortensen; J F Hansen
Journal:  Cardiology       Date:  1994       Impact factor: 1.869

9.  Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.

Authors:  Kim Fox; Ian Ford; Ph Gabriel Steg; Michal Tendera; Michele Robertson; Roberto Ferrari
Journal:  Eur Heart J       Date:  2009-08-31       Impact factor: 29.983

10.  Selective heart rate reduction with ivabradine slows ischaemia-induced electrophysiological changes and reduces ischaemia-reperfusion-induced ventricular arrhythmias.

Authors:  Fu Siong Ng; Iqbal T Shadi; Nicholas S Peters; Alexander R Lyon
Journal:  J Mol Cell Cardiol       Date:  2013-02-09       Impact factor: 5.000

View more
  21 in total

1.  PON1 L55M and Q192R gene polymorphisms and CAD risks in patients with hyperlipidemia : Clinical study of possible associations.

Authors:  H Chen; S Ding; M Zhou; X Wu; X Liu; J Liu; Y Wu; D Liu
Journal:  Herz       Date:  2017-08-23       Impact factor: 1.443

Review 2.  Myocardial ischemia and coronary disease in heart failure.

Authors:  Beniamino R Pagliaro; Francesco Cannata; Giulio G Stefanini; Leonardo Bolognese
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

3.  Association between heart rate and cardiovascular death in patients with coronary heart disease: A NHANES-based cohort study.

Authors:  Ruicong Ma; Jianbo Gao; Shiyuan Mao; Zhirong Wang
Journal:  Clin Cardiol       Date:  2022-03-30       Impact factor: 3.287

Review 4.  Expert consensus document: A 'diamond' approach to personalized treatment of angina.

Authors:  Roberto Ferrari; Paolo G Camici; Filippo Crea; Nicolas Danchin; Kim Fox; Aldo P Maggioni; Athanasios J Manolis; Mario Marzilli; Giuseppe M C Rosano; José L Lopez-Sendon
Journal:  Nat Rev Cardiol       Date:  2017-09-07       Impact factor: 32.419

Review 5.  Effects of paraoxonase 1 gene polymorphisms on heart diseases: Systematic review and meta-analysis of 64 case-control studies.

Authors:  Yazmín Hernández-Díaz; Carlos Alfonso Tovilla-Zárate; Isela Esther Juárez-Rojop; Thelma Beatriz González-Castro; Candelario Rodríguez-Pérez; María Lilia López-Narváez; José Manuel Rodríguez-Pérez; José Francisco Cámara-Álvarez
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

6.  Effect of voluntary breathing exercises on stable coronary artery disease in heart rate variability and rate-pressure product: a study protocol for a single-blind, prospective, randomized controlled trial.

Authors:  Qing Wu; Lin Liu; Xin Jiang; Yao-Yao Hu; Qiu-Shi Liang; Zhi-Song He; Yuan Xue; Wei Zhu; Zai-Xiang Tang; Yun-Ying Hou; Qi Zhao; Xiao-Hua Wang
Journal:  Trials       Date:  2020-07-01       Impact factor: 2.279

7.  Discharge Heart Rate After Hospitalization for Myocardial Infarction and Long-Term Mortality in 2 US Registries.

Authors:  Venkatesh Alapati; Fengming Tang; Esti Charlap; Paul S Chan; Paul A Heidenreich; Philip G Jones; John A Spertus; Vankeepuram Srinivas; Jorge R Kizer
Journal:  J Am Heart Assoc       Date:  2019-02-05       Impact factor: 5.501

8.  Association of resting heart rate and its change with incident cardiovascular events in the middle-aged and older Chinese.

Authors:  Jing Tian; Yu Yuan; Miaoyan Shen; Xiaomin Zhang; Meian He; Huan Guo; Handong Yang; Tangchun Wu
Journal:  Sci Rep       Date:  2019-04-25       Impact factor: 4.379

9.  Tachycardia and Pre-existing Chronic Kidney Disease Are Predictors of the Worse Clinical Outcomes in Patients Recently Hospitalized With Acute Heart Failure.

Authors:  Leonardo P Suciadi; Kevin Wibawa; Giovanni Jessica; Joshua Henrina; Irvan Cahyadi; Bryany T Santi; Titus K Hariadi; Firman Tedjasukmana; Nathania M Kristanti; Elisa F Pakpahan; Reynold A Manullang; Antono Sutandar
Journal:  Cureus       Date:  2021-06-21

10.  Predictors of all-cause 1-year mortality in myocardial infarction patients.

Authors:  Qing Ye; Jie Zhang; Likun Ma
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.